The preclinical evaluation of a second-generation antivenom for treating snake envenoming in India

ABSTRACT: In this study, by employing chromatographic purification of the bulk, we have significantly enhanced the preclinical performance of the conventional Indian antivenom product. The effectiveness of the test batches of this ‘second-generation’ antivenom was evaluated using a variety of in vitro and in vivo preclinical assays, including venom recognition and toxicity and pathology neutralisation. The outcomes of these experiments demonstrated the significantly superior performance of the purified product over all other major commercial Indian antivenoms.

INSTRUMENT(S):

ORGANISM(S): Equus Caballus (horse)

TISSUE(S): Blood Serum

SUBMITTER: Kartik Sunagar  

LAB HEAD: Dr. Kartik Sunagar

PROVIDER: PXD029436 | Pride | 2022-04-04

REPOSITORIES: Pride